Tower Research Capital LLC (Trc) Codex Dna, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	3,082 Added 13400.0%	3,105 $5,000
Q4 2023 Feb 13, 2024	BUY	N/A	23 New	23 $0
Q2 2023 Aug 14, 2023	SELL	N/A	-3,003 Reduced 75.81%	958 $1,000
Q1 2023 May 09, 2023	SELL	$1.3 - $2.15 $6,476 - $10,711	-4,982 Reduced 55.71%	3,961 $12,000
Q4 2022 Feb 10, 2023	BUY	$1.12 - $1.69 $3,155 - $4,760	2,817 Added 45.98%	8,943 $11,000
Q3 2022 Nov 10, 2022	SELL	$1.7 - $2.36 $2,254 - $3,129	-1,326 Reduced 17.79%	6,126 $10,000
Q2 2022 Aug 15, 2022	BUY	$1.8 - $6.45 $9,700 - $34,759	5,389 Added 261.22%	7,452 $13,000
Q1 2022 May 12, 2022	SELL	$4.12 - $10.36 $2,175 - $5,470	-528 Reduced 20.38%	2,063 $11,000
Q4 2021 Feb 14, 2022	BUY	$6.31 - $11.96 $10,739 - $20,355	1,702 Added 191.45%	2,591 $28,000
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $9,023 - $17,673	889 New	889 $10,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.